
Icosagen is an Estonian biotechnology company providing custom research programs and services to the Biopharmaceutical industry, including antibody discovery, protein production, and GMP manufacturing. Formed in 1999 as Quattromed AS, it was renamed Icosagen in 2009. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Icosagen (Estonia), Estonia, covering academic research published from 2001 to 2025. Read More.
Open Access Percentage
75%
Total
Publications
106
Total Open
Publications
80
Total
Citations
1.9K
Open Access
Percentage
75%
Total
Publications
106
Total Open
Publications
80
Total
Citations
1.9K
Breakdown
Publisher Open
20%
Both
41%
Other Platform Open
14%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 63%
41
Hybrid 22%
14
No Guarantees 15%
10
Other Platform Open
Domain 63%
37
Institution 58%
34
Other Internet 25%
15
Preprint 14%
8
Public 5%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 37 |
doaj.org OAI-PMH Repository | Institution | 20 |
DOI | Other Internet | 8 |
Unknown Repository | Other Internet | 7 |
University of Oslo | Institution | 6 |
bioRxiv | Preprint | 6 |
Royal Netherlands Academy of Arts and Sciences | Institution | 5 |
kuleuven.be OAI-PMH Repository | Institution | 4 |
helsinki.fi OAI-PMH Repository | Institution | 3 |
Figshare | Public | 3 |